Crispr Therapeutics AG vs Five Below Inc — how do they compare? Crispr Therapeutics AG trades at $50.76 (market cap $4.99B), while Five Below Inc trades at $190 (market cap $10.59B). The key difference: Five Below Inc is far larger — about 2.1× Crispr Therapeutics AG's market cap, and Five Below Inc is trading nearer its 52-week high, Crispr Therapeutics AG nearer its low. Which is the better fit depends on your goals.
| CRSP | FIVE | |
|---|---|---|
Market Cap | $4.99B | $10.59B |
Sector | Health | Consumer Staples |
52-Week High | $76.78 | $247.71 |
52-Week Low | $44.34 | $131.94 |
Enterprise Value | $3.33B | $11.48B |
Trailing returns across standard periods
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics
Read more on FIVE →